Ifabotuzumab (KB-004) is an antibody targeting EphA3+ cells, significantly reducing CCR10+ cells and improving pulmonary fibrosis in humanized NSG mice.
Purity:
>95%
CAS Number:
[2147698-66-4]
Target:
Ephrin Receptor|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted